Autophinib
99%
- Product Code: 99596
CAS:
1644443-47-9
| Molecular Weight: | 346.73 g./mol | Molecular Formula: | C₁₄H₁₁ClN₆O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD31560472 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Autophinib is primarily used in research settings to study autophagy, a cellular process involved in the degradation and recycling of cellular components. It functions as an inhibitor of autophagy by targeting the kinase activity of VPS34, a key enzyme in the autophagy pathway. Researchers utilize Autophinib to investigate the role of autophagy in various physiological and pathological conditions, such as cancer, neurodegenerative diseases, and infections. By inhibiting autophagy, it helps in understanding how the suppression of this process affects cell survival, tumor growth, and resistance to therapies. Additionally, Autophinib is employed in preclinical studies to explore its potential as a therapeutic agent, particularly in cancers where autophagy plays a critical role in promoting cell survival under stress conditions. Its application extends to the development of combination therapies, where it is tested alongside other drugs to enhance treatment efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | €206.31 |
+
-
|
Autophinib
Autophinib is primarily used in research settings to study autophagy, a cellular process involved in the degradation and recycling of cellular components. It functions as an inhibitor of autophagy by targeting the kinase activity of VPS34, a key enzyme in the autophagy pathway. Researchers utilize Autophinib to investigate the role of autophagy in various physiological and pathological conditions, such as cancer, neurodegenerative diseases, and infections. By inhibiting autophagy, it helps in understanding how the suppression of this process affects cell survival, tumor growth, and resistance to therapies. Additionally, Autophinib is employed in preclinical studies to explore its potential as a therapeutic agent, particularly in cancers where autophagy plays a critical role in promoting cell survival under stress conditions. Its application extends to the development of combination therapies, where it is tested alongside other drugs to enhance treatment efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :